Liraglutide mitigates dexamethasone-induced fatty acid synthase (FASN) and the cluster of differentiation36 (CD36) expression: a potential treatment for glucocorticoid-induced non-alcoholic fatty liver disease (NAFLD). - Selim DH; Mokhlis HA; Elsayed AM; Shatat AS; Salama SA; Ismail RS (Naunyn-Schmiedeberg's archives of pharmacology, 2025)